Cancer,
Год журнала:
2024,
Номер
130(23), С. 4012 - 4019
Опубликована: Авг. 11, 2024
Abstract
This
commentary
highlights
a
need
for
comprehensive
measures
of
structural
racism
tailored
to
cancer
health
disparities,
in
particular
Black–White
disparities
multiple
myeloma
(MM).
Recent
political
and
social
calls
advances
the
ability
quantitate
have
led
rapidly
growing
research
on
consequences
racism.
However,
date,
most
studies
used
unidimensional
that
do
not
capture
cumulative
influences
or
enable
identification
factors
responsible
driving
disparities.
Furthermore,
may
reflect
aspects
relevant
underlying
disease
processes
risks.
study
proposes
multifaceted
approach
measuring
MM
includes
comprehensive,
disease‐
at‐risk
population‐tailored
environmental
data
biomarkers
susceptibility
progression
related
biological
changes
associated
with
Such
novel
improve
assess
influence
which
advance
understanding
etiology
differences
observed
by
racialized
groups.
Abstract
Objective
Initiating
postoperative
radiotherapy
(PORT)
within
6
weeks
of
surgery
for
head
and
neck
squamous
cell
carcinoma
(HNSCC)
is
included
in
the
National
Comprehensive
Cancer
Network
Clincal
Practice
Guidelines
a
Commission
on
quality
metric.
Factors
associated
with
delays
starting
PORT
have
not
been
systematically
described
nor
synthesized.
Data
Sources
PubMed,
Scopus,
CINAHL.
Review
Methods
We
studies
describing
demographic
characteristics,
clinical
factors,
or
social
determinants
health
delay
(>6
weeks)
patients
HNSCC
treated
United
States
after
2003.
Meta‐analysis
odds
ratios
(ORs)
was
performed
nonoverlapping
datasets.
Results
Of
716
unique
abstracts
reviewed,
21
were
systematic
review
15
meta‐analysis.
Study
sample
size
ranged
from
19
to
60,776
patients.
In
meta‐analysis,
factors
black
race
(OR,
1.46,
95%
confidence
interval
[CI]:
1.28‐1.67),
Hispanic
ethnicity
1.37,
CI,
1.17‐1.60),
Medicaid
no
insurance
2.01,
1.90‐2.13),
lower
income
1.38,
1.20‐1.59),
admission
>7
days
2.92,
2.31‐3.67),
30‐day
hospital
readmission
1.29‐1.47).
Conclusion
Patients
at
greatest
risk
initiating
guideline‐adherent
include
those
who
are
minoritized
communities,
socioeconomic
status,
experience
challenges.
These
findings
provide
foundational
evidence
needed
deliver
targeted
interventions
enhance
equity
care
delivery.
JNCI Monographs,
Год журнала:
2023,
Номер
2023(62), С. 255 - 264
Опубликована: Ноя. 1, 2023
Abstract
Over
the
past
2
decades,
population
simulation
modeling
has
evolved
as
an
effective
public
health
tool
for
surveillance
of
cancer
trends
and
estimation
impact
screening
treatment
strategies
on
incidence
mortality,
including
documentation
persistent
inequities.
The
goal
this
research
was
to
provide
a
framework
support
next
generation
models
identify
leverage
points
in
control
continuum
accelerate
achievement
equity
care
minoritized
populations.
In
our
framework,
systemic
racism
is
conceptualized
root
cause
inequity
upstream
influence
acting
subsequent
downstream
events,
which
ultimately
exert
physiological
effects
mortality
competing
comorbidities.
To
date,
most
investigating
racial
have
used
individual-level
race
variables.
Individual-level
proxy
exposure
racism,
not
biological
construct.
However,
single-level
variables
are
suboptimal
proxies
multilevel
systems,
policies,
practices
that
perpetuate
inequity.
We
recommend
future
designed
capture
relationships
between
outcomes
replace
or
extend
with
measures
structural,
interpersonal,
internalized
racism.
Models
should
investigate
actionable
levers,
such
changes
care,
education,
economic
structures
policies
increase
reductions
health-care–based
interpersonal
This
integrated
approach
could
novel
approaches,
make
explicit
different
highlight
data
gaps
interactions
model
components
mirroring
how
factors
act
real
world,
inform
we
collect
equity,
generate
results
policy.
JNCI Monographs,
Год журнала:
2023,
Номер
2023(62), С. 231 - 245
Опубликована: Июль 14, 2023
Abstract
Purpose
Structural
racism
could
contribute
to
racial
and
ethnic
disparities
in
cancer
mortality
via
its
broad
effects
on
housing,
economic
opportunities,
health
care.
However,
there
has
been
limited
focus
incorporating
structural
into
simulation
models
designed
identify
practice
policy
strategies
support
equity.
We
reviewed
studies
evaluating
highlight
challenges,
future
directions
capture
this
concept
modeling
research.
Methods
used
the
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analyses-Scoping
Review
Extension
guidelines.
Articles
published
between
2018
2023
were
searched
including
terms
related
race,
ethnicity,
cancer-specific
all-cause
mortality,
racism.
included
of
United
States.
Results
A
total
8345
articles
identified,
183
included.
Studies
different
measures,
data
sources,
methods.
For
example,
20
studies,
residential
segregation,
one
component
racism,
was
measured
by
indices
dissimilarity,
concentration
at
extremes,
redlining,
or
isolation.
Data
sources
registries,
claims,
institutional
linked
area-level
metrics
from
US
census
historical
mortgage
data.
Segregation
associated
with
worse
survival.
Nine
location
specific,
segregation
measures
developed
Black,
Hispanic,
White
residents.
Conclusions
range
are
available
provide
a
set
recommendations
best
practices
modelers
consider
when
models.
Journal of Cancer Survivorship,
Год журнала:
2024,
Номер
unknown
Опубликована: Март 28, 2024
Abstract
Purpose
We
reviewed
existing
personalized,
web-based,
interactive
decision-making
tools
available
to
guide
breast
cancer
treatment
and
survivorship
care
decisions
in
clinical
settings.
Methods
The
study
was
conducted
using
the
Preferred
Reporting
Items
for
Systematic
reviews
Meta-Analyses
extension
Scoping
Reviews
(PRISMA-ScR).
searched
PubMed
related
databases
web-based
developed
support
from
2013
2023.
Information
on
each
tool’s
purpose,
target
population,
data
sources,
individual
contextual
characteristics,
outcomes,
validation,
usability
testing
were
extracted.
completed
a
quality
assessment
tool
International
Patient
Decision
Aid
Standard
(IPDAS)
instrument.
Results
found
54
providing
personalized
outcomes
(e.g.,
recurrence)
recommendations
chemotherapy)
based
stage),
genomic
21-gene-recurrence
score),
behavioral
smoking),
insurance)
characteristics.
Forty-five
validated,
nine
had
undergone
testing.
However,
validation
included
mostly
White,
educated,
and/or
insured
individuals.
average
score
of
16
(range:
6–46;
potential
maximum:
63).
Conclusions
There
wide
variation
quality,
validity,
tools.
Future
studies
should
consider
diverse
populations
development
Implications
survivors
are
It
is
important
both
physicians
carefully
these
before
them
decisions.
JNCI Monographs,
Год журнала:
2023,
Номер
2023(62), С. 246 - 254
Опубликована: Ноя. 1, 2023
Abstract
Population
models
of
cancer
reflect
the
overall
US
population
by
drawing
on
numerous
existing
data
resources
for
parameter
inputs
and
calibration
targets.
Models
require
that
are
appropriately
representative,
collected
in
a
harmonized
manner,
have
minimal
missing
or
inaccurate
values,
adequate
sample
sizes.
Data
resource
priorities
modeling
to
support
health
equity
include
increasing
availability
1)
arise
from
uninsured
underinsured
individuals
those
traditionally
not
included
health-care
delivery
studies,
2)
relevant
exposures
groups
historically
intentionally
excluded
across
full
control
continuum,
3)
disaggregate
categories
(race,
ethnicity,
socioeconomic
status,
gender,
sexual
orientation,
etc.)
their
intersections
conceal
important
variation
outcomes,
4)
identify
specific
populations
interest
clinical
databases
whose
outcomes
been
understudied,
5)
enhance
records
through
expanded
elements
linkage
with
other
types
(eg,
patient
surveys,
provider
and/or
facility
level
information,
neighborhood
data),
6)
decrease
misclassified
underrecognized
populations,
7)
capture
potential
measures
effects
systemic
racism
corresponding
intervenable
targets
change.
JNCI Journal of the National Cancer Institute,
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 27, 2024
Abstract
The
central
premise
of
this
article
is
that
a
portion
the
established
relationships
between
social
determinants
health
and
racial
ethnic
disparities
in
cancer
morbidity
mortality
mediated
through
differences
rates
biological
aging
processes.
We
further
posit
using
knowledge
about
could
enable
discovery
testing
new
mechanism-based
pharmaceutical
behavioral
interventions
(“gerotherapeutics”)
to
differentially
improve
survivors
from
minority
populations
reduce
disparities.
These
hypotheses
are
based
on
evidence
lifelong
adverse
contribute
(“social
aging”),
with
individuals
minoritized
groups
experiencing
accelerated
(ie,
steeper
slope
or
trajectory
over
time
relative
chronological
age)
more
often
than
nonminoritized
groups.
Acceleration
can
increase
risk,
age
onset,
aggressiveness,
stage
many
adult
cancers.
There
also
documented
negative
feedback
loops
whereby
cellular
damage
caused
by
its
therapies
act
as
drivers
additional
aging.
Together,
these
dynamic
intersectional
forces
outcomes
vs
populations.
highlight
key
targetable
mechanisms
potential
applications
reducing
discuss
methodological
considerations
for
preclinical
clinical
impact
gerotherapeutics
Ultimately,
promise
will
require
broad
societal
policy
changes
address
structural
causes
ensure
equitable
access
all
control
paradigms.
JNCI Monographs,
Год журнала:
2023,
Номер
2023(62), С. 178 - 187
Опубликована: Авг. 14, 2023
Abstract
Background
Populations
of
African
American
or
Black
women
have
persistently
higher
breast
cancer
mortality
than
the
overall
US
population,
despite
having
slightly
lower
age-adjusted
incidence.
Methods
Three
Cancer
Intervention
and
Surveillance
Modeling
Network
simulation
teams
modeled
disparities
between
female
populations
population.
Model
inputs
used
racial
group–specific
data
from
clinical
trials,
national
registries,
nationally
representative
surveys,
observational
studies.
Analyses
began
with
in
population
sequentially
replaced
parameters
for
to
quantify
percentage
morality
attributable
differences
demographics,
incidence,
access
screening
treatment,
variation
tumor
biology
response
therapy.
Results
were
similar
across
3
models.
In
2019,
incidence
competing
accounted
a
net
‒1%
disparities,
while
subtype
stage
distributions
mean
20%
(range
models
=
13%-24%),
3%
3%-4%)
disparities.
Treatment
majority
disparities:
17%
16%-19%)
treatment
initiation
61%
57%-63%)
real-world
effectiveness.
Conclusion
Our
model
results
suggest
that
changes
policies
target
improvements
could
increase
equity.
The
findings
also
highlight
efforts
must
extend
beyond
targeting
equity
include
high-quality
completion.
This
research
will
facilitate
future
modeling
test
effects
different
specific
policy
on
MDM Policy & Practice,
Год журнала:
2024,
Номер
9(1)
Опубликована: Янв. 1, 2024
Introduction.
Personalized
web-based
clinical
decision
tools
for
breast
cancer
prevention
and
screening
could
address
knowledge
gaps,
enhance
patient
autonomy
in
shared
decision-making,
promote
equitable
care.
The
purpose
of
this
review
was
to
present
evidence
on
the
availability,
usability,
feasibility,
acceptability,
quality,
uptake
support
their
integration
into
Methods.
We
used
Preferred
Reporting
Items
Systematic
reviews
Meta-Analyses
extension
Scoping
Reviews
Checklist
conduct
review.
searched
6
databases
identify
literature
development,
validation,
acceptability
testing,
practice
settings.
Quality
assessment
each
tool
conducted
using
International
Patient
Decision
Aid
Standard
instrument,
with
quality
scores
ranging
from
0
63
(lowest-highest).
Results.
identified
10
9
screening.
included
individual
(e.g.,
age),
genomic
risk
factors),
health
behavior
alcohol
use)
characteristics.
Fourteen
race/ethnicity,
but
no
incorporated
contextual
factors
insurance,
access)
associated
cancer.
All
were
internally
or
externally
validated.
Six
had
undergone
usability
testing
samples
including
White
(median,
71%;
range,
9%–96%),
insured
(99%;
97%–100%)
women,
college
education
higher
(60%;
27%–100%).
developed
tested
academic
Seven
(37%)
showed
potential
practice.
an
average
score
21
(range,
9–39).
Conclusions.
There
is
limited
diverse
nonacademic
settings
potentially
improve
access
these
tools.
Highlights
19
personalized,
interactive,
Web-based
Breast
outcomes
personalized
based
characteristics
age,
medical
history),
BRCA1/2),
race
ethnicity,
behaviors
smoking).
did
not
include
insurance
status,
facilities)
that
contribute
outcomes.
Validation,
feasibility
mostly
among
and/or
patients
some
(or
higher)
JNCI Monographs,
Год журнала:
2023,
Номер
2023(62), С. 167 - 172
Опубликована: Сен. 14, 2023
Despite
significant
progress
in
cancer
research
and
treatment,
a
persistent
knowledge
gap
exists
understanding
addressing
care
disparities,
particularly
among
populations
that
are
marginalized.
This
deficit
has
led
to
"data
divide,"
where
certain
groups
lack
adequate
representation
cancer-related
data,
hindering
their
access
personalized
data-driven
care.
divide
disproportionately
affects
marginalized
minoritized
communities
such
as
the
U.S.
Black
population.
We
explore
concept
of
deserts,"
wherein
entire
populations,
often
based
on
race,
ethnicity,
gender,
disability,
or
geography,
comprehensive
high-quality
health
data.
Several
factors
contribute
data
deserts,
including
underrepresentation
clinical
trials,
poor
quality,
limited
digital
technologies,
rural
lower-socioeconomic
communities.The
consequences
divides
deserts
far-reaching,
impeding
equitable
precision
medicine
perpetuating
disparities.
To
bridge
this
divide,
we
highlight
role
Cancer
Intervention
Surveillance
Modeling
Network
(CISNET),
which
employs
population
simulation
modeling
quantify
emphasize
importance
collecting
quality
from
various
sources
improve
model
accuracy.
CISNET's
collaborative
approach,
utilizing
multiple
independent
models,
offers
consistent
results
identifies
gaps
knowledge.
It
demonstrates
impact
systemic
racism
incidence
mortality,
paving
way
for
evidence-based
policies
interventions
eliminate
suggest
potential
use
voting
districts/precincts
unit
aggregation
future
CISNET
modeling,
enabling
targeted
informed
policy
decisions.